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Abstract
Background:  Prior research has revealed large differences in health and mortality across
countries, socioeconomic groups, and individuals. Russia experiences one of the world's highest
levels of all-cause and cardiovascular mortality, great mortality differences within the population,
and a heavy burden of ill health. Psychological stress has been suggested as a likely explanation of
health loss and premature death in Russia and Eastern Europe. However, physiological mechanisms
connecting stress with health in Russia remain unclear since existing epidemiological data are scarce
and limited to conventional risk factors.
Method and Design: The survey on Stress Aging and Health in Russia (SAHR) is addressing this
knowledge gap by collecting an unusually rich database that includes a wide range of reported
information, physical and cognitive health outcomes, and biomarkers in a sample of Muscovite men
and women aged 55 and older. The total planned sample size is 2,000 individuals. The sample was
randomly selected from epidemiological cohorts formed in Moscow between the mid-1970s and
the 1990s and from medical population registers. The baseline data collection was carried out from
December 2006 to June 2009. Interviews and medical tests were administered at hospital or at
home according to standardized protocol. Questionnaire information includes health, socio-
demographic characteristics, economic well-being, cognitive functioning, and batteries on stress
and depression. Biomarkers include anthropometry, grip strength, resting ECG, conventional
cardiovascular factors of risk such as lipid profile and blood pressure, and other biochemical
parameters such as those related to inflammation, glucose and insulin resistance, coagulation,
fibrinolysis, and stress hormones. In addition to these measurements, SAHR includes dynamic
biomarkers provided by 24-hour ECG (Holter) monitoring. This method continuously registers the
beat-to-beat heart rate in naturalistic conditions without restrictions on normal daily activities. It
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provides information about heart functioning, including heart rate variability and ischemic and
arrhythmic events.
Re-examination of the study subjects will be conducted in 2009–2011 and will focus on health,
functional status, economic conditions, behaviors, and attitudes towards aging. The subjects are
also followed up for mortality and non-fatal health events.
Discussion: The SAHR will produce a valuable set of established and novel biomarkers combined
with self-reported data for the international research community and will provide important
insights into factors and biological mechanisms of mortality and health losses in Russia.
Background
Between- and within-country disparities that had been
decreasing during most of the twentieth century [1,2]
began to increase in the 1980s [3-7]. In particular, the
mortality gap between industrialized countries of Eastern
and Western Europe has grossly increased [8]. In Eastern
Europe, Russia is experiencing very high levels of all-cause
and cardiovascular mortality and large differences in mor-
tality between socioeconomic groups [5,9]. In addition to
the toll of premature death, the Russian population has a
high prevalence of ill health and low levels of healthy life
expectancy [10,11].
Health behaviors are well established as factors of mortal-
ity in Russia [12], but along with conventional cardiovas-
cular risk factors they can explain only a part of the excess
death and socioeconomic mortality differences within the
country [13-17].
It has been suggested that restricted life chances and psy-
chosocial stress could be important contributors to poor
health both in Russia and Eastern Europe [18-20]. Signif-
icant evidence connects relative deprivation and lack of
life chances with exposure to various stressors [21-23].
Studies show the importance of effort-reward imbalance,
hostility, social isolation, depression, low perceived con-
trol, uncertainty, and hopelessness [24-30]. For the Rus-
sian population, it has been suggested that the oppressive
totalitarian regime as well as the drastic and poorly gov-
erned political and economic reforms of the 1990s were
associated with high psychosocial stress and mortality
increase [19,20,31]. It was found that mortality increases
were greater in Russian regions that in the 1990s experi-
enced larger socioeconomic shocks due to steeper pace of
reforms, higher income inequality and unemployment
[32,33].
In addition to classic questions on health behaviors and
conventional cardiovascular risk factors, the SAHR pro-
gram addresses the stress hypothesis through a range of
questions on stress, coping, psychological and mental
conditions.
How does stress, as reflected by these data, get "under the
skin"? It is generally known that repetitive stress reactions
connected with interruptions of the normal homeostatic
process have the potential to suppress the body's adapta-
bility. The concept of allostatic load was designed to
reflect physiological toll caused by the cumulation of
stresses [34,35]. It provides a possible basis for behavioral
and physiological mechanisms by which genes, early life
experiences, the living and working environment, inter-
personal relationships, diet, exercise (physical activity),
sleep, and other factors can affect the body's chemistry,
neuro-physiological regulation and functioning over a
lifetime. The allostatic load score is based on a set of bio-
chemical parameters that express major multi-system
functioning. Namely, these are lipid transport system
parameters as markers of atherosclerosis; carbohydrate
metabolism parameters as markers of metabolic syn-
drome; and markers of diabetes and insulin resistance,
stress hormones epinephrine, norepinephrine, DHEA-S,
and cortisol as markers of neuro-endocrine system distur-
bances, by measuring 12-hour hypothalamic-pituitary-
adrenal axis activity and sympathetic nervous system
activities. Coagulation system parameters are used as
atherothrombosis risk markers, and inflammation param-
eters are used as indicators of atherosclerosis progression.
Point measurements of biomarkers, however, do not pro-
vide full information about real-life functioning that
includes variations in bodily systems due to physiological
cycles, diurnal rhythms, and responses to external influ-
ences. A review by Steptoe and Marmot suggests that
dynamic measurement (or monitoring) that includes con-
tinuous recording of physiological response to exposures,
has the potential to greatly enhance research opportuni-
ties [36]. Monitoring of subjects in ordinary settings, over
hours or days, can provide especially valuable data that
reflect not only characteristic levels of biomarkers but also
patterns of their variation around these levels under nor-
mal life conditions. Studies involving blood pressure
monitoring have produced a number of important results
[37-40]. The SAHR program includes 24-hour heart rate
(Holter) monitoring.BMC Public Health 2009, 9:293 http://www.biomedcentral.com/1471-2458/9/293
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Elevated heart rate (HR) is an established risk factor of
mortality and morbidity due to cardiovascular and other
chronic diseases [41-49]. Although HR is simple to meas-
ure, its point measurements can be influenced by a variety
of occasional environmental factors [50,51], limiting
comparability and interpretation of results [52]. On the
contrary, HR recorded over 24 hours has high reproduci-
bility and is a better prognostic indicator than the tradi-
tionally measured resting heart rate in a hospital setting
[48]. As a dynamic marker of challenge, HR is sensitive to
external influences and responsive to stress.
Holter monitoring is a relatively inexpensive and non-
invasive way of obtaining extensive data on the dynamics
of cardiac functioning. The method is notable for the rich-
ness of data it provides. It produces large amounts of
information by registering 70,000–100,000 consecutive
cardio-cycles over a 24-hour period. These are multidi-
mensional time series reflecting the organism's function-
ing via cardiovascular activity and its regulation by the
sympathetic and parasympathetic influences of the auto-
nomic nervous system. Holter tapes provide data on HR
level, heart rate variability (HRV), and on cardiac events
such as episodes of ischemia and various arrhythmias.
Reduced HRV is shown to be linked to negative emotions
(anxiety and hostility), social isolation, and anger [53,54].
The research value of HRV analyses of Holter data col-
lected from the general population has been recognized
recently, and some promising results are already available.
It has been shown that reduced HRV is associated with
increased incidence of heart attacks in the general popula-
tion aged 55 to 75 years with no initially registered
pathology [55]. Another population study has demon-
strated that elevated HRV indices are associated with
higher risk of death among the elderly [56].
Circadian variations in heart rate reflect the sleep-waking
pattern. Circadian changes predict life-threatening events
such as myocardial infarction in the early morning hours
[57-59]. Nocturnal heart rate elevations are recognized as
a marker of severity of diabetes mellitus [52]. The ratio of
average daytime to average nighttime cardiac rhythm is a
stable characteristic of healthy individuals, and its devia-
tions from a normal level have been found to be associ-
ated with disease progression [52,60-63]. Blunted
circadian variation in the autonomic regulation of heart
rate was found in US veterans with so-called Gulf War syn-
drome [64].
ECG events such as episodes of ischemia (ST depression)
and arrhythmia (especially ventricular arrhythmia) are
strong predictors of myocardial infarction, atrial fibrilla-
tion, heart arrest, and arrhythmic syncope [65].
Aims of the Survey
The SAHR is designed to investigate physiological path-
ways of disease and death in a Moscow population that is
exposed to high psychological stress and experiences high
incidence of chronic disease and premature death. To
address this general objective, the following specific aims
are pursued:
- To conduct a biodemographic survey of men and
women aged 55 and older, who reside in Moscow and
closely resemble the socio-demographic structure of
its general population, through collection of a wide set
of major physiological function biomarkers, including
Holter monitoring data.
- To perform descriptive analyses for estimating the
prevalences and age patterns of health outcomes, dis-
eases, health conditions as well as various biomarkers.
- To examine the links: (i) between health outcomes
and biomarkers, with a focus on determining the
incremental value of Holter monitoring as an addi-
tional source of research information; (ii) between
biomarkers, socio-demographic characteristics, and
stress; and (iii) sex- and age-related differences in
stress-biomarker and health-biomarker associations.
- To conduct a re-examination survey of participants
approximately 2.5 years after the baseline survey. To
trace survey participants for mortality during another
five years after the follow-up survey. To estimate feasi-
bility of these data to predict morbidity and mortality.
- To study these longitudinal data, using statistical
methods of survival analysis, with a focus on deter-
mining the incremental value of Holter information to
predict morbidity and mortality.
- To prepare a user-friendly dataset that includes all the
collected data and which can be used by the research
community.
The general concept of the SAHR was worked out through
a series of meetings of the International Study Team (IST)
held at the Max Planck Institute of Demographic Research
(MPIDR) in 2001–2006. The IST unites researchers from
Germany, Denmark, Italy, Russia, and the United States.
Sampling procedures, study questionnaire modules, pro-
cedures for realizing the biomarker collection, and other
components of the study logistics were tried out in the
Moscow Pilot Study (MPS) of 201 individuals aged 65
and older that was carried out in 2003–2004. The MPS
outcomes indicated that the dynamic Holter parameters
can be linked to perceived health, cognition, and stress
and can potentially add value to the known risk factorsBMC Public Health 2009, 9:293 http://www.biomedcentral.com/1471-2458/9/293
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[66]. In 2004–2005, these outcomes were used for plan-
ning the main survey.
The survey on Stress Aging and Health in Russia was
launched in September 2006 as a core part of the project
"Biodemography of Disease and Death in Moscow" [67]
(Biodemography of Disease and Death, 2008). The
project is a collaborative effort of Duke University (Dur-
ham, USA), the Max Planck Institute for Demographic
Research (MPIDR, Rostock, Germany), and the State
Research Centre for Preventive Medicine (SRCPM, Mos-
cow, Russia).
Stages of SAHR
The SAHR data collection program covers five project
years. It began in September 2006 and will be completed
by the end of June 2011. The initial recruitment and base-
line survey have taken place, starting December 2006 and
to be completed by the end of June 2009. The re-examina-
tion survey will be performed in 2009–2011.
Follow-up of the study participants for mortality along
with telephone tracing of participants is being carried out
over the 2008–2011 period. It is planned to continue with
the mortality follow-up of SAHR participants until at least
the end of 2016.
Methods and Design
The study sample
As do many studies, SAHR faced an inevitable tradeoff
between the collection of sophisticated biomedical data
for every individual and the sample size. The sample size
was estimated using statistical patterns provided by previ-
ously available data: the MPS data and data on the sur-
vival of Moscow epidemiological cohorts (MONICA and
Lipid Research Clinics cohorts specified in the next para-
graph). We checked whether a sample size of 1,800 or
more individuals aged 55 and older – similar to the statis-
tical distributions and associations of the MPS sample –
would be sufficient to estimate quantities and regression
coefficients with a power of at least 0.90 with statistical
significance p < 0.05. The findings confirmed that relative
changes of about 5% between values of the principal
health and stress variables measured at the baseline and at
the re-examination surveys would be statistically signifi-
cant. Monte-Carlo simulations confirmed the sample size
for the coefficients of regressions connecting measures of
health and psychological stress with risk scores based on
conventional and Holter biomarkers. Using the survival
data of the Moscow epidemiological cohorts, we also
found that it would be possible to obtain statistically sig-
nificant (p < 0.05) estimates of the coefficients of propor-
tional hazard regressions connecting mortality to
conventional biomarkers with statistical power exceeding
0.90. In the interest of descriptive analysis, we decided to
include at least 100 males and 100 females in every five-
year age group from 55–59 to 75–79 and at least 80 males
and 80 females aged 80 and above. In addition, each of
the age groups 55–64, 65–74, and 75 and older should
constitute about one third of the sample.
The SAHR sample comprises two unequal parts: a random
selection of members of past epidemiological cohorts
listed in the registry of the international studies' partici-
pants of the SRCPM in Moscow and another random
selection from the Moscow Outpatient Clinics registry.
The first part of 1,860 individuals was randomly selected
from seven epidemiological cohorts of the SRCPM that
were first screened beginning in the mid-1970s. Data col-
lected from these cohorts have been used in various inter-
national projects in the field of cardiovascular
epidemiology [68-71]. The seven cohorts are the Lipid
Research Clinics (LRC1) of 1975–77, the LRC2 of 1979–
81, the Multinational Monitoring of Trends and Determi-
nants in Cardiovascular Disease first cohort (MONICA1)
of 1983–85, the MONICA2 cohort of 1988–89, the "Shi-
gan" cohort of 1990–91, the MONICA3 cohort of 1992–
94, and the MONICA4 cohort of 2000–01.
The data collection programs of the seven studies
included a nearly identical part related to collection of
conventional cardiovascular factors such as blood pres-
sure, cholesterol and lipid levels, weight, height, electro-
cardiographic symptoms of ischemia; self-reported
information on diet, smoking, chest pain, and angina;
and basic socio-demographic characteristics. At first
screenings, members of the seven cohorts were aged 40 to
59. Initial sizes of the cohorts varied from nearly 4,000
individuals in LRC1 and MONICA1 to about 800 individ-
uals in MONICA4. The biggest cohorts were formed in the
1970s and the early 1980s. The initial total size of the
seven cohorts was 14,402. According to the follow-up
data, on 1 January 2007 the number of cohort survivors
living in Moscow was 8,128. Of this total, 6,221 individ-
uals were aged 55 to 85 and were eligible for further selec-
tion to the SAHR (Table 1). From this universe, about 930
men and 930 women were recruited to form the first part
of the Survey sample.
Table 1: Subjects of the seven cohorts eligible for recruitment to 
SAHR
Age, years Males Females Total
55–64 1,315 965 2,280
65–74 1,395 847 2,242
75–84 1,109 436 1,545
85+ 115 39 154
Total 3,934 2,287 6,221BMC Public Health 2009, 9:293 http://www.biomedcentral.com/1471-2458/9/293
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The majority of individuals from the seven epidemiologi-
cal cohorts were resident in Moscow before the second
half of the 1980s. During the soviet era, migration to Mos-
cow was very limited because of special administrative
restrictions. However, migration to Moscow from other
parts of Russia and from abroad has intensified since the
early 1990s. According to the last all-Russia census of
2002, the proportion of people who moved to Moscow
after 1985 constituted 7% of the total population aged
55+ [72]. To ensure that this part of the Muscovite popu-
lation is present in the Survey sample, 70 men and 70
women who moved to Moscow after 1985 are to be added
to the sample. These 140 subjects constitute the second part
of the Survey sample. Prospective candidates were ran-
domly selected from the Moscow Outpatient Clinics' reg-
istry.
In the MPS of 2002–04, the response rate was 67%. For
the main SAHR, we expected a 65% response rate. So far
(after two years of fieldwork), the response rate is 64%.
Recruitment
Recruitment to the study was launched after the vital sta-
tus and addresses of potential participants had been
updated. The recruitment scheme for the SAHR consisted
of three subsequent steps: preliminary notice by letter, tel-
ephone contact(s), and checking into the survey. Starting
in December 2006, the project manager of the SRCPM in
Moscow contacted prospective participants by letter,
enclosing basic information about the aims of the study,
its contents, and potential benefits such as a high-quality
medical examination that could provide early diagnosis of
any serious condition.
Approximately one week later, the written invitation was
followed by a direct telephone call in order to learn
whether the subject would like to participate in the study.
For each candidate subject, phone contacts can last no
longer than one month with telephone calls performed at
least twice a week on different days and at different times,
with registration of results of each call. For subjects who
did not want to participate, their reasons were noted, if
given. If the subject was ready to participate, a date for a
visit to the hospital or a date for testing and interviewing
at home was agreed upon. Participants were asked to pre-
pare a 12-hr urine sample in a clean container before the
first clinic or home visit, to be collected at the time of the
first visit. All subjects gave their informed consent before
the examination.
Those who were ready to participate in the survey but were
not examined for three months or who missed the visit
three times were included in the cohort anyway but
regarded as non-responders. If a potential participant was
unavailable, the project manager attempted to find out
why the subject was absent and note the reason.
At the beginning of the hospital or home visit, partici-
pants are registered into the survey and receive their
unique ID-numbers. Only specially assigned medical per-
sonnel of the Moscow survey team have access to actual
participants' names. All data components and documents
are linked by means of ID-numbers.
On the first day of examination, SAHR participants are
offered a snack. They are also offered free blood pressure
devices to be used for the home blood pressure measure-
ments. Within one week after the examination, partici-
pants receive information about health problems detected
by the tests and related advice for further diagnosis and
treatment.
Baseline survey
Interviewing
The SAHR questionnaire includes well-established ques-
tions and batteries. Many of questions were piloted in the
MPS in 2002–2003. The questionnaire modules are listed
in Table 2.
The socio-demographic characteristics module (3) has ques-
tions on marital status, children, education, and occupa-
tional status. The questions on household composition
(module 4) were adopted from the Household Question-
naire used in the Russian Longitudinal Monitoring Survey
(RLMS) [73]. Childhood and early life conditions (module 5)
are addressed by questions on place of residence in child-
hood, ethnic origin, relative wealth of parental family
compared to others, nutrition in childhood, and parental
Table 2: Modules of the baseline survey questionnaire
Module 1. First contact by telephone (or face-to-face)
with a respondent or a proxy informant
Module 2. Information about the interview
Module 3. Socio-demographic characteristics Module 4. Household composition
Module 5. Childhood and early life conditions Module 6. Health behaviors
Module 7. Health and quality of life Module 8. Functional status
Module 9. Major life events Module 10. Wealth, economic conditions, and income-generating activities
Module 11. Supportive relations and social capital Module 12. Stress and locus of control
Module 13. Cynical distrust Module 14. Depression
Module 15. Coping with stressBMC Public Health 2009, 9:293 http://www.biomedcentral.com/1471-2458/9/293
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education [74]. Similar questions are asked in the Health,
Alcohol and Psychosocial Factors in Eastern Europe
(HAPIEE) study [75].
The health behaviors (module 6) includes questions on
smoking and about frequency and amounts of consumed
alcoholic beverages. Taking into account the important
role of alcohol in Russia, the CAGE four-question battery
[76] is also used. Finally, there is a set of more detailed
questions adopted from the Izhevsk Family Study [77,78].
These questions are focused on heavy and binge drinking.
The health and quality of life (module 7) includes the 36-
item Short Form Health Survey (SF-36) [79]. It has ques-
tions on physical ability, emotional problems, bodily
pain, general health status, vitality, social functioning,
and mental conditions. Functional status is assessed (in
module 8) by questions on comparative health and on
diseases from a slightly modified standard 35-item list.
Cardiac symptoms are described by the classic Rose test
batteries on angina and the pain of possible infarction
[80]. Cognitive functioning is assessed by the Mini-Mental
State Examination (MMSE) [81] in the form that was used
in the Longitudinal Study of Aging Danish Twins (LSADT)
[82].
The list of major life events (module 9) is based on the Hol-
mes-Rahe Scale [83] and is slightly adapted to the Russian
context. The list includes various events, especially adverse
ones that can potentially cause stress [84,85].
Economic conditions (module 10) are assessed by questions
on relative wealth compared to others, property, house-
hold assets, sources of income, kinds of expenses that the
household can afford, and the share of income spent on
food and non-food items. These questions were used in
many surveys including the Russian Longitudinal Moni-
toring Survey (RLMS) and the Russian Generations and
Gender Program [86]. The social capital questions (module
11) related to help and support provided to others and by
others and questions on trust in others were adopted from
a survey on social capital in Russia by Rose [87].
Perceived stress (module 12) is evaluated by Cohen's Stress
Scale [88], an additional set of questions on psychological
stress at work and at home, and questions on financial
stress [89]. Perceived ability to control circumstances of
one's own life is captured by the locus of control ques-
tions that were used in studies of psychosocial stress and
health in Eastern Europe [90,75].
Hostility and distrust (module 13) are assessed by the 8-
item Cynical Distrust Scale, which has been often used in
epidemiological studies [91,92]. Depression  symptoms
(module 14) are determined by means of the depression
section of the Cambridge Mental Disorders of the Elderly
Examination (CAMDEX) instrument [93], which was also
used in LSADT [82]. Finally, coping with stress (module 15)
is assessed by the Brief Cope scale [94], which allows the
identification of 14 coping strategies (such as coping by
seeking emotional support by others, giving up, using
alcohol as a stress-reliever, etc).
Biomedical tests
Table 3 summarizes biomarkers measured in SAHR base-
line and re-examination surveys. They can be split into
seven groups: anthropometry, physical measurements,
ambulatory (home) blood pressure, two groups of labora-
tory tests (blood biochemistry and urine biochemistry),
office ECG, and 24-hour Holter monitoring. Finally, par-
ticipants' photographs are taken.
In most cases, the medical examinations are carried out by
trained medical personnel at the hospital (SRCPM). If
potential participants are unable or unwilling to come
there (12%), the examinations are carried out in the home
by personnel with the same qualifications.
Anthropometry includes body height measured with a wall-
mounted stadiometer, body weight measured with cali-
brated scales, waist and hip circumferences measured with
a calibrated tape in the standing position.
Physical measurements include resting blood pressure (BP)
measured according to standardized procedure [95] on
right arm using a manual sphygmomanometer after a 10-
minute rest. The first and the fifth Korotkoff phases are
used to define systolic and diastolic blood pressures,
respectively. BP is measured three times, and the averages
are taken as the office SBP and DBP values.
Grip strength is a measure of isometric muscle strength that
correlates with the strength of many other muscle groups.
It is measured by a hand-held Smedley Dynamometer
"Scandidact" (Denmark). The upper arm is held against
the trunk and the elbow in 90 degrees flexion [96]. Three
trials with brief pauses are performed for each hand, and
subjects are encouraged to exert the maximal effort. The
same grip strength instrument and similar protocols have
been used in other studies such as the English Longitudi-
nal Study of Aging (ELSA) [97], the two Danish twin stud-
ies, MADT and LSADT [82], and the Eastern European
HAPIEE [75].
Ambulatory or home blood pressure protocol consists of
repetitive BP measurements at home over three consecu-
tive days. Omron automatic monitor HEM-712 is used.
The self-measurements are made on the right arm, twice a
day in the sitting position, in the morning and in the
evening. The home BP results are not biased by the so-BMC Public Health 2009, 9:293 http://www.biomedcentral.com/1471-2458/9/293
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Table 3: SAHR biomarkers and their use in baseline and re-examination surveys
Biomarker Baseline survey Re-examination
Anthropometry
Height xx
Weight xx
Waist circumference xx
Hip circumference xx
Physical measurements
Office SBP xx
Office DBP xx
Resting HR during 30 seconds x x
Right grip strength xx
Left grip strength xx
Ambulatory (home) blood pressure
Day 1: SBP (morning, evening) x
Day 1: DBP (morning, evening) x
Day 2: SBP (morning, evening) x
Day 2: DBP (morning, evening) x
Day 3: SBP (morning, evening) x
Day 3: DBP (morning, evening) x
Routine blood tests
Haemoglobin x
Cell counts x
Color index x
ESR x
Blood biochemistry
Total cholesterol x
LDL cholesterol x
Triglycerides x
HDL cholesterol x
Glucose x
Glycosylated haemoglobin x
C-reactive protein x
Gamma-glutamyl transferase (GGT) x
Insulin x
Dehydroepiandrosterone sulphate (DHEA-S) x
Fibrinogen x
Activity of fibrinilysis (ECLT) x
Interleikin-6 (IL-6) x
Urine biochemistryBMC Public Health 2009, 9:293 http://www.biomedcentral.com/1471-2458/9/293
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called "white coat" effect characteristic of the office BP.
Some research suggests that they are also more reproduci-
ble, better predict future BP [98], cardiovascular events
[99], and mortality [100].
Blood tests are taken on venous blood with amount about
12 ml, drawn from cubital vein after overnight fasting and
sampled for the routine blood tests and measurement of
fasting plasma concentrations of glucose, insulin, serum
total and high-density lipoprotein (HDL) cholesterol,
triglycerides, fibrinogen, glycosylated hemoglobin
(HbA1c), dehydroepiandrosterone sulphate (DHEA-S),
interleukin-6 (IL-6), C-reactive protein (CRP), and
gamma-glutamyl transferase (GGT). Whole blood is used
for routine blood tests to count white blood cells and to
assess erythrocyte sedimentation rate (ESR) and HbA1c,
which is measured by High Performance Liquid Chroma-
tography Technique (ECLT). Glucose level is measured by
the glucose oxidase method. Serum total cholesterol, HDL
cholesterol, and triglycerides are measured enzymatically
on an auto-analyzer "Airone 200" (Italy) using "Human"
reagent kits (Germany). Serum LDL cholesterol is calcu-
lated with the equation of Friedewald [101].
GGT activity is measured by colorimetric kinetic method
on the auto-analyzer "Airone 200" with the "Human" rea-
gent kits. Fibrinogen is measured according to the Clauss
method. Activity of fibrinolysis is estimated as a time of
spontaneous lysis of euglobulin fraction clot. Serum levels
of DHEA-S and of insulin are determined by radioimmu-
noassay. IL-6 level is determined by quantitative sandwich
ELISA-technique. CRP concentration is measured by
means of high-sensitive particle-enhanced rate immunon-
ephelometry.
Urine biochemistry
The 12-hour overnight excretion of cortisol, epinephrine,
and norepinephrine reflects basal non-stimulated level of
activity of the hypothalamic-pituitary-adrenal axis and
sympathetic nervous system. Free epinephrine and nore-
pinephrine are measured by high performance liquid
chromatography, while cortisol is measured by radioim-
munoassay. Creatinine level is measured by photometric
colorimetric test. Values of cortisol, epinephrine, and
norepinephrine are expressed in micrograms per gram of
creatinine excreted during the same overnight period. In
this way, the values are adjusted for variation in absolute
amounts of the urine that are related to variations in body
size and other factors [102,103].
Resting ECG
The baseline standard supine 12-lead electrocardiogram
with four consecutive cardio-cycles (25 mm/s) is per-
formed, coded according to the Minnesota Code [104]
and examined by two independent experts. Over the past
two decades, the Minnesota Code, which provides a clas-
sification of electrocardiographic morphology, has
become a universal standard for ECG classification in epi-
demiological studies [105].
Continuous 24-hour ECG monitoring
Holter monitoring is performed with the Schiller Holter
System, manufactured by Schiller AG (Switzerland) in
accordance with the guidelines of the ACC/AHA [106].
Holter recorders (3-channel MICROVIT MT-101 digital
devices) and electrodes are fitted to the participant's body
by a qualified nurse and are carried by participants over
the next 24 hours. Quality of the ECG initial signal is
checked by visual inspection through a special window on
the recording device. ECG recording is not disturbing and
causes hardly any changes in participants' normal daily
activities. After copying the recorded ECG series to the MT
Holter System, two types of data files are produced: binary
file of continuous ECG time series and ASCII file of RR-
interval time series. The participants also keep diaries
briefly tracing their main activities as well as episodes of
bodily discomfort, pain, other symptoms, physical efforts,
beginning and end of sleep.
Creatinine x
Cortisol x
Norepinephrine x
Epinephrine x
Office ECG
Minnesota-coded records, characteristics of ECG patterns, ischemia events (ST-
segment), arrhythmia events, defects of conduction, ECG heart rate
x
Continuous 24-hour ECG (Holter) monitoring x
Facial photography x
Table 3: SAHR biomarkers and their use in baseline and re-examination surveys (Continued)BMC Public Health 2009, 9:293 http://www.biomedcentral.com/1471-2458/9/293
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Preliminary cleaning of the Holter series is performed by
trained cardiologists using the standard analytical toolkit
of the Schiller System MT200 and MT210. Each Holter
series is analyzed in semi-automated mode that allows the
cardiologist to remove artifacts and to identify event pat-
terns including arrhythmia, rhythm pauses, sinus tachy-
cardia/bradycardia, and ischemia. Holter records with
numerous artifacts and fewer than 18 hours of analyzable
data are excluded from further analysis. Figure 1 demon-
strates a fragment of Holter series, one ECG event (prema-
ture ventricular beat), and some ECG parameters.
In general, three types of biomarkers are estimated from
the Holter ECG files. The first type reflects the heart rate,
including its average, upper and lower extremes over 24
hours, and its day-to-night (circadian) variation. (The
daytime period is defined as time between 8 am and 8 pm.
The nighttime period lasts from 0 am to 4 am). Process of
heart repolarization is described by QT and corrected QT
interval values corresponding to the average, maximum,
and minimum heart rates.
The second type of Holter biomarkers reflects the heart
rate variability related to cardiac regulation by the auto-
nomic nervous system. HRV parameters are calculated
from the RR series. Only normal-to-normal (NN) inter-
vals (intervals between adjacent normal heart beats) are
included in the HRV analysis. A 5-minute interval of the
RR series is included in the HRV analysis only if at least
80% of its RR intervals correspond to normal heart beats.
Generally, HRV parameters are classified as either time or
frequency domain parameters [107,108]. Methods for
estimation of most of the time domain parameters are
internationally standardized. The study uses SDANN
(standard deviation of the averages of normal-to-normal
intervals within all 5-minute segments); SDNN (standard
deviation of all normal-to-normal intervals); SDNN index
(mean of the standard deviations of all normal-to-normal
intervals within all 5-minute segments); pNN50 (percent-
age of adjacent normal-to-normal intervals that vary by
more than 50 ms); and rMSSD (the square root of the
mean of the sum of successive differences of normal-to-
normal intervals).
The frequency domain parameters of HRV are based on
spectral analysis of RR series. Methods for their calcula-
tion are standardized to a lesser extent than those for the
time domain parameters. The following frequency
domain parameters are used: POWER – total power of the
spectrum of tachogram in the frequency range ≤ 0.4 Hz;
VLF – power in the very low frequency range ≤ 0.04 Hz; LF
– power in the low frequency range 0.04–0.15 Hz; HF –
power in the high frequency range 0.15–0.4 Hz; and LF/
HF – the ratio LF/HF. While the HF component is consid-
ered as a pure index of efferent vagal activity, the LF com-
ponent is influenced by the sympathetic control [107].
The third type of data is related to cardiac events. Arrhyth-
mia events include supraventricular and ventricular pre-
mature beats, pauses of heart rhythm, periods of asystole,
episodes of supraventricular and ventricular tachycardia,
and other rhythm disturbances. Ischemia is detected on
ST-segment trend built by the Holter System from the
ECG series. This trend allows one to identify ST-segment
deviations. The cardiac events are described by frequen-
cies of their occurrences and durations of the abnormal
episodes.
Facial photography
Photographs of participants' faces are taken from distance
of 120 cm. They can be used for age assessment by asses-
sors [109]. The assessed age is considered as a possible
biomarker of successful aging.
Implementation of the baseline survey
Before beginning the fieldwork, the study plans were
approved by the Ethical Committee of the SRCPM in Mos-
cow and the Institutional Review Board at Duke Univer-
sity in Durham, USA. Study planning, data processing and
checks are performed jointly by researchers from MPIDR,
A fragment of Holter series showing several ECG parameters and an ECG event (premature ventricular beat) Figure 1
A fragment of Holter series showing several ECG parameters and an ECG event (premature ventricular beat).
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SRCPM, and Duke University with advice from the study
consultants.
SAHR questionnaires were translated from English into
Russian and rechecked on the basis of the back transla-
tion. The Russian version was then tested in Moscow on a
small number of respondents. Training sessions for the
Moscow team members were completed in June-August
2006. Interviewing is performed by five trained interview-
ers with two additional interviewers doing interviews
from time to time.
Fieldwork is performed by the Moscow SAHR team based
at SRCPM. The team includes (for most of the time) a
fieldwork supervisor, eight physicians, seven nurses, a
statistician, and an epidemiologist. All team members
have experience of prior epidemiological studies. Analysis
of Holter series is performed by three qualified cardiolo-
gists.
The survey procedure includes a fixed sequence of steps
and lasts two days. Most of the tests are performed on the
first day. For cortisol and creatinine measurements, partic-
ipants are asked to collect the first portion of overnight
urine (excreted between 8 pm and 8 am) over the night
prior to the first-day appointment. A second portion of
urine for catecholamines is excreted between 8 pm and 8
am overnight following the first day of examination. The
second urine portion and the Holter recorder are returned
to the SAHR team on the second day. The completed
home blood pressure table is sent to SRCPM within four
to five days by postal mail.
The first-day steps are:
- Signing of informed consent
- Registration in survey and issue of personal IDN
- Face-to-face interview
- Collection of first 12-hour urine portion for creati-
nine and cortisol measurements
- Venous blood drawing
- Eating a snack
- Office measurements of blood pressure and heart
rate
- Grip strength measurement
- Instruction on how to measure home blood pressure
and provision of (free) blood pressure gauge
- Office ECG and anthropometric measurements
- Installing of Holter recorder on participant's body
- Taking participant's photograph
- Providing container for second urine portion and
envelope with home blood pressure table
The second-day steps are:
- Returning second urine portion to SRCPM
- Removal and return of Holter recorder to SRCPM
Data processing
For each study participant, the whole contact process (dis-
patch of the invitation letter, telephone calls, and results
of negotiations) is coded in an Excel file. Another Excel
file traces the examination process. It provides dates and
times for all steps of the study procedure as well as per-
sonal codes of SAHR team members who completed pro-
cedures with the individual. It also includes dates of
forwarding blood and urine samples to the laboratory and
dates of getting their results. A special Excel macro trans-
forms the individual files into two summary files named
List#1 and List#2. The first file documents for the whole
sample the process of recruitment that ends with success-
ful recruitment, refusal (with or without stated reason), or
inability to get in contact with the potential participant.
The second file documents progress in interviews and
medical testing.
Initially, the interview data are recorded on paper ques-
tionnaire forms. Afterwards, they are computerized two
times and checked for inconsistencies between the two
entries. The final interview data are stored in a SAS file. In
this file, each individual's record contains 547 variables.
Results of biomedical tests (except for Holter monitoring)
are stored in the second SAS file after decoding of office
ECG records and receiving laboratory results. In this file,
each record contains 120 variables. Parameters of Holter
series are computerized in the third file, which contains
71 variables. Personal IDNs allow merging of these data
files. In addition, folders are set up with individuals' Hol-
ter binary files, RR-interval ASCII files, and JPG files with
photographs.
The data files are further checked at SRCPM and at
MPIDR. These checks include analysis for correct filtering
through the questionnaire, checks of variable ranges, as
well as some simple tabulations, correlations, and regres-
sions.BMC Public Health 2009, 9:293 http://www.biomedcentral.com/1471-2458/9/293
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Follow-up and re-interview
The study participants are followed up by a phone call 14–
18 months after the examination and by a trace of their
vital status via residential registers. The follow-up phone
call is to check whether they are still present at their regis-
tered places of residence and to update their vital and
health status. Participants or their relatives are asked to
provide brief information about any hospitalization or
onset or aggravation of serious diseases experienced since
the last contact. The most reliable information about par-
ticipants' deaths and changes of location is obtained from
residential registers. Such information usually has a lag
time of 12 to 15 months.
For an average study participant, the re-interview will take
place about 2.5 years after the first interview. Several ques-
tions address health events experienced since the baseline
examination. A brief questionnaire includes seven mod-
ules replicating the baseline survey and one additional
module highlighting attitudes towards aging (Table 4).
The latter module consists of five questions adopted from
the Philadelphia Geriatric Center Morale Scale [110,111].
It shows whether a person perceives his (her) own aging
in an optimistic or pessimistic way.
If the study participant dies between the first and second
interviews, the team will try to reach a proxy informant for
preliminary information about the date and cause of
death. The precise information about deaths will later be
obtained from the residential registry.
The third column of Table 3 indicates several biomedical
tests that will be administered for a second time during
the re-examination: anthropometric measurements, grip
strength, and office BP.
Statistical analysis
The study data will provide a rich array of biomarkers col-
lected from the general Moscow population. Despite the
relatively small sample size, these data will open the door
to numerous research opportunities.
Three principal types of statistical analysis will be carried
out: descriptive and cross-sectional analyses, longitudinal
analyses linking morbidity and mortality events and
health changes with baseline predictors, and within-indi-
vidual analyses of Holter time series.
As most of the collected biomarkers and some question-
naire indicators are newly obtained for the Russian popu-
lation, descriptive and cross-sectional analyses of the
baseline data will be important. They will highlight levels
of these respective variables, show their variation across
age, sex, and other dimensions and enable comparison
with equivalent data from other populations. In particu-
lar, there is clear potential for comparison with the Cardi-
ovascular Health Study and the MacArthur Study on
Successful Aging in the United States, the Taiwan Social
Environment and Biomarkers of Aging Study, the ELSA,
the two Danish twin studies (LSADT and MADT), and the
Eastern European HAPIEE study.
The analyses of associations will be focused on links
within and between four major data blocks: measures of
subjective and objective health, characteristics of socio-
demographic status and wealth, characteristics of psycho-
logical stress, and biomarkers including Holter parame-
ters. The block of health measures includes reported
general health, reported diseases and invalidity; SF36
summary measures of physical functioning such as role
limitations and bodily pain; objective cognitive and phys-
ical performance indicators such as MMSE, recall scores,
and hand grip strength. The socio-demographic status is
described by education, relative and absolute income,
socio-occupational position, marital status, perceived rel-
ative wealth, proportion of income spent on food, and
affordable expenses. Psychological status is characterized
by the SF36 measures of role limitation due to emotional
health, vitality, mental health, and social functioning;
Cohen's stress scale; locus of control questions; battery on
stress at work, at home, and financial stress; cynical dis-
trust scale; depression scale; and coping with stress scale.
Finally, the block of biomarkers includes conventional
cardiovascular risk factors (BP, lipid levels, and anthro-
pometry); biochemical markers of allostatic load; conven-
tional cardiac symptoms (Rose Angina, office heart rate,
and ischemia signs on office ECG); ambulatory BP and
especially its morning elevation; and major Holter mark-
ers (heart rate and its extremes; time and frequency
domain parameters of heart rate variability; heart rate
characteristics of sleep, circadian variation, and sleep-
awake transition; tachycardia and bradicardia; prevalence
of ECG distortions, and episodes of arrhythmia and
ischemia.
Table 4: Modules of the brief questionnaire for the re-examination survey
Module 1. Information about the interview Module 2. Marital status and economic conditions
Module 3. Health and quality of life Module 4. Health behaviors
Module 5. Functional status Module 6. Major life events
Module 7. Locus of control and depression Module 8. Attitudes towards agingBMC Public Health 2009, 9:293 http://www.biomedcentral.com/1471-2458/9/293
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The first cross-sectional analyses will assess links between
subjective and objective health, between health and
biomarkers; between health, socio-demographic charac-
teristics and biomarkers; and between health, psychologi-
cal stress and biomarkers. Among biomarkers, special
attention will be paid to Holter-based variables. Analyses
will be focused on their additional value and on locating
the most informative and the best predicting parameters.
The OLS, logit, ordinal logit, and multiple logit regres-
sions as well as simultaneous equation models will make
up the main statistical work to be performed.
The re-examination survey and the follow-up of study par-
ticipants will provide data on mortality and morbidity
events as well as on changes in health, disease, cognitive
and physical performance variables registered by the re-
examination survey. These data will be used for longitudi-
nal analyses by means of proportional hazard and Pois-
son regressions. Preliminary estimates show that during
the period between the baseline and the re-examination
surveys about 150 deaths and about 100 serious health
events can be expected. Information about the changes in
health will be available for the whole sample. An addi-
tional follow-up of the SAHR participants for five years
after the end of the Survey in 2011 would increase the
number of observed death events to 560–580.
Use of aggregate scores instead of the original variables
will be a reasonable option for many analyses. This
approach enables one to reduce dimensions and to
increase the statistical power of data without significant
loss of explanatory capacity. SAHR data permit using
many pre-defined questionnaire scores based either on
batteries of questions (MMSE score, stress and depression
scores) or on sets of biomarkers (the allostatic load score,
Framingham score, and others). Additional scores can be
constructed from the original variables on the basis of
regression and factor analyses.
A special section of analyses will be devoted to the contin-
uous ECG time series. First, mathematical procedures and
algorithms for robust estimation of RR series from the
ECG signal and computation of frequency domain indices
will be worked out. At a later stage, statistical models for
automated estimates and informative measurements from
the 24-hour series will be explored. In particular, auto-
mated recognition of awake-sleep and the sleep-awake
transitions is one of the priority problems. This can be
done by exploiting the statistical techniques provided by
hidden Markov models. The ability of such models to
effectively segment ECG trajectories has been proven in
several studies [112,113].
Discussion
SAHR will produce unique insights into the determinants
of chronic conditions and ill health in Russia, a region
where mortality has long been very high and has been fur-
ther increasing over the last two decades. Reasons for this
unusual trend are poorly understood, especially with
regard to older ages where chronic health conditions and
biological factors are of greater importance. So far, even
some very basic objective data on the physical and cogni-
tive health of Russians are not available. The SAHR aims
at closing this gap by providing a large amount of objec-
tive measurements and biomedical data. The study's col-
lection of biomarkers combines well-established
biomarkers with newer markers of allostatic load that pre-
sumably measure cumulative stress and physiological toll.
The novel dynamic data of 24-hour Holter monitoring
allows to evaluate the functioning of the cardiac system, as
well as to see how the system responds to routines and
challenges of everyday life.
As in many other studies rich in medical data, the SAHR
has a relatively small sample size. Although it represents a
disadvantage (especially for the longitudinal analyses of
mortality and morbidity), it can be (at least partly) treated
by the use of changes in health as the dependent variable
and/or by the use of aggregate biomarker or questionnaire
scores as the independent variables.
The following three data problems do not influence any
analysis within the study, but could cause difficulties for
comparisons with external data. First, SAHR participants
represent the Moscow population, yet that population dif-
fers in some respects from the entire Russian population.
Most importantly, Moscow has a greater proportion of
people with higher education and those with higher
income. Use of weights can (at least partly) treat this prob-
lem and bring the SAHR sample closer to the national
population.
Second, the SAHR faces a well-known problem related to
a certain selectivity of participants to the sample. For
example, response rates tend to be higher in women and
in people with higher education. We partly compensate
for this problem by a moderate over-sampling of the
under-represented groups and by use of appropriate
weights for international comparisons.
Third, any quantitative comparison of Holter parameters
with equivalent values from other studies should be made
with caution and accompanied by checks of comparabil-
ity. The latter depend on Holter systems, algorithms for
detection of R peaks, estimation of HRV parameters and
ECG patterns. Some Holter parameters (for example,
overall heart rate) are quite robust, but many parameters
are sensitive to these factors. Ideally, Holter biomarkersBMC Public Health 2009, 9:293 http://www.biomedcentral.com/1471-2458/9/293
Page 13 of 16
(page number not for citation purposes)
should be computed by one and the same software from
ECG files of different origin.
The SAHR will provide the most comprehensive set of
new biomedical and questionnaire data for the Russian
population. These data will enhance research for disclos-
ing mechanisms underlying the heavy burden of death
and disease among Muscovites aged 55 and older. The
study will also contribute to the understanding of general
relationships between objective life conditions, psycho-
logical stress, and biological and health changes in
humans. Analysis of the Holter series will provide new
opportunities to observe continuous functioning of the
heart and its regulation by the autonomous nervous sys-
tem under conditions of everyday life. These data have
potential to add further value to the known biomarkers
and will help researchers take the next step towards health
monitoring systems of the future.
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